The therapy of diabetes insipidus with 1-desamino-8-D-arginine-vasopressin (autor's transl)
Novotný, P.
Casopis Lekaru Ceskych 112(35): 1083-1084
1973
ISSN/ISBN: 0008-7335 PMID: 4751289 Document Number: 65843
Document emailed within 1 workday
Related Documents
Limal, J.M.; Mugner, E.; Czernichow, P. 1977: Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin) Archives Francaises de Pediatrie 34(10): 965-972Brink, H.S.; Derkx, F.H.; Boomsma, F.; Brommer, E.J.; Schalekamp, M.A. 1993: 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus Netherlands Journal of Medicine 43(1-2): 5-12
Schück, O.; Cort, J.H.; Stríbrná, J.; Skopková, J.; Jost, K. 1975: A new synthetic analog of vasopressin, desamino-6 carba-(8-D-arginin)-vasopressin, active against diabetes insipidus refractory to vasopressin and adiuretin spofa Casopis Lekaru Ceskych 114(6): 172-175
Derkx, F.H.; Man in 't Veld, A.J.; Jones, R.; Reid, J.L.; Schalekamp, M.A. 1983: DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin? Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 1(2): 58-61
Fjellestad-Paulsen, A.; Tubiana-Rufi, N.; Harris, A.; Czernichow, P. 1987: Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin Acta Endocrinologica 115(3): 307-312
Somerfield, S.D.; Hocken, A.G. 1977: Desamino arginine vasopressin (DDAVP) as a diagnostic agent New Zealand Medical Journal 86(600): 472-473
Köhler, M.; Hellstern, P.; Miyashita, C.; von Blohn, G.; Wenzel, E. 1986: Comparative study of intranasal, subcutaneous and intravenous administration of desamino-D-arginine vasopressin (DDAVP) Thrombosis and Haemostasis 55(1): 108-111
Tamas, G.; Chatel, R. 1975: Powdered lysine-vasopressin (vasopressin spray) in the treatment of diabetes insipidus Orvosi Hetilap 116(4): 191-194
Henneberry, H.P.; Slater, J.D.; Eisen, V.; Führ, S. 1992: Arginine vasopressin response to hypertonicity in hypertension studied by arginine vasopressin assay in unextracted plasma Journal of Hypertension 10(3): 221-228
Dubrovina, N.I.; Papsuevich, O.S.; Chipens, G.I. 1991: The slowing of the extinction of a conditioned reaction and the antiamnesic action of arginine vasopressin and des-glycine-(8-arginine) vasopressin Farmakologiia i Toksikologiia 54(5): 5-7
Ford, S.M.; Lumpkin, H.L. 1986: Transient vasopressin-resistant diabetes insipidus of pregnancy Obstetrics and Gynecology 68(5): 726-728
Czaja, M.; Kruszyński, M.; Hinko, A.; Soloff, M.S. 1994: Arginine vasopressin antagonism of oxytocin-stimulated PGE2 release from rabbit amnion cells and the activities of thioanalogs of oxytocin and arginine vasopressin Polish Journal of Pharmacology 46(5): 429-437
Tsukaguchi, H.; Matsubara, H.; Inada, M. 1998: Vasopressin type 2 receptor mutations in congenital diabetes insipidus Nihon Rinsho. Japanese Journal of Clinical Medicine 56(7): 1848-1855
Gerards, L.J.; van Leeuwen, E.F.; Donckerwolcke, R.A.; Kuijten, R.H. 1975: Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP Nederlands Tijdschrift Voor Geneeskunde 119(33): 1269-1272
Knoers, N.V.; Deen, P.M. 2000: From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus Nederlands Tijdschrift Voor Geneeskunde 144(50): 2402-2404
Villamor, J.; Hita, J.; Barreiro, P.; Ortiz Vázquez, J.; Vãzquez, J.J. 1971: Familial primary vasopressin resistant diabetes insipidus sensitive to biguanide Revista Clinica Espanola 121(1): 51-62
Laczi, F.; Julesz, J.; Janáki, T.; Iványi, T.; Boda, K.; László, F. 1990: Regulation of vasopressin release in primary hypothyroidism and Addison's disease as well as in central diabetes insipidus Orvosi Hetilap 131(22): 1175-1180
Ebenezer, I.S. 1994: The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors Methods and Findings in Experimental and Clinical Pharmacology 16(5): 315-321
Watanabe, H.; Lau, D.C.; Guyn, H.L.; Wong, N.L. 1997: Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome Clinical and Investigative Medicine 20(4): 211-223
Lumholtz, I.B. 1977: Drug information. Therapeutic main group: antidiuretics. Preparation DDAVP (deamino arginine vasopressin); Minurin, Lypressinum; Insipid retard; Vasopressin Sygeplejersken 77(30): 21